Two-Year Randomized Controlled Trial and Follow-up of Dialectical Behavior Therapy vs Therapy by Experts for Suicidal Behaviors and Borderline Personality Disorder

Clicks: 370
ID: 116864
2006
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 6 articles by views in archives of general psychiatry

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Context Dialectical behavior therapy (DBT) is a treatment for suicidal behavior and borderline personality disorder with well-documented efficacy. Objective To evaluate the hypothesis that unique aspects of DBT are more efficacious compared with treatment offered by non–behavioral psychotherapy experts. Design One-year randomized controlled trial, plus 1 year of posttreatment follow-up....
Reference Key
linehan2006archivestwo-year Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marsha M. Linehan;Katherine Anne Comtois;Angela M. Murray;Milton Z. Brown;Robert J. Gallop;Heidi L. Heard;Kathryn E. Korslund;Darren A. Tutek;Sarah K. Reynolds;Noam Lindenboim;
Journal archives of general psychiatry
Year 2006
DOI
DOI not found
URL
https://dx.doi.org/10.1001/archpsyc.63.7.757
Keywords
borderline personality disorder Suicide posttreatment followup feeling suicidal suicidal behavior dialectical behavior therapy psychiatric hospitalization suicide attempt self-injurious behavior

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.